Ranbaxy Laboratories will file an appeal against a New Jersey district court order restraining Teva Pharmaceuticals and Ranbaxy Pharmaceuticals Inc from selling RPI's quinapril tablets (5, 10, 20, and 40 mg) on a challenge filed by Pfizer.
Addressing a press briefing, Union Health Secretary Rajesh Bhushan said healthcare workers and frontline workers need not register themselves as their database has been populated on to the Co-WIN vaccine delivery management system in a bulk manner.
As of Thursday, he said total deaths in America due to COVID-19 is over 527,000. That's more deaths than in World War I, World War II, the Vietnam War, and 9/11 combined, he said.
The approval by the Drugs Controller General of India (DCGI) was given on the basis of recommendations submitted by a COVID-19 subject expert committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO).
Snooping is one of the oldest peccadilloes of man, observes Ambassador M K Bhadrakumar.
Biocon chairperson and managing director Kiran Mazumdar-Shaw is in a firefighting mode, as the company she founded was forced to call off a blockbuster deal with global pharmaceutical major Pfizer.
India's generic drug manufacturer, Dr Reddy's Laboratories, suffered a setback when a US' Court of Appeals ruled that it infringed on Pfizer Pharmaceutical company's patent for the blood pressure medicine Norvasc.
Last year, India's agricultural exports to the United States topped $5 billion.
Currently, the govt directly caps prices of 348 formulations at the average price of all medicines in a particular segment with at least 1% market share
Students who have received admission to foreign universities are struggling with unexpected delays, additional living costs and scarcity of vaccine supplies.
The worry is that India's cavalier approach to intellectual property may catch on in other parts of the developing world
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Cambridge, Massachusetts-based Moderna's announcement comes just a week after Pfizer and Biontech said their COVID-19 vaccine candidate was found to be more than 90 per cent effective in preventing COVID-19 in participants.
'We lost our place in being first in the epidemic, when it hit India so hard, but we were actually the epicentre of the epidemic from essentially April 2020, for almost an entire year. We had such high cases. We were the country that had the most mixed response.'
Asian shares dragged their feet on Tuesday.
The Delhi High Court on Friday stayed the ban on some fixed dose combination (FDC) drugs of Glaxo SmithKline, Wockhardt and Laboratories Griffon but said action against their sale could be taken in the absence of valid sale and marketing licence.
India battles big pharma over cough syrup abuse, reducing supplies
Companies run till now by mostly their promoters are increasingly inducting professionals to head their teams.
AstraZeneca Plc and the University of Oxford are facing questions about their Covid-19 vaccine and whether regulators would quickly authorise its emergency use after the pharma company acknowledged an error in the vaccine dosage received by some participants and other irregularities and omissions, according to the New York Times.
''None of the existing vaccines have 100% efficacy.' 'Each vaccine will work openly on a certain percentage of the population.'
However, in two different dose regimens, the vaccine's efficacy was 90 per cent in one and 62 per cent in the other.
Over time, as more mutations occur, the vaccine may need to be altered.
Companies say they follow global standards in India as well
After healthcare and frontline workers, priority will be given to those above 50 years of age and the under-50 population groups with co-morbidities numbering around 27 crore, it added.
Biotech company denies all charges.
Less than three months after roaring into us market with generic for cholesterol-reducing Lipitor, Dept of Justice files for permanent injunction against Ranbaxy.
Scientists around the world, including in India, suggest it hasn't been tested properly given the time constraint and there may not be enough evidence to prove its efficacy.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Mylan had sued the United States Food and Drugs Administration for providing the exclusive right to Ranbaxy, alleging the permission was given on the basis of 'falsified data'.
Severe price cuts help multinationals ramp up growth, gain market share.
Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the domestic pharma firms working on the coronavirus vaccines in India.
The ministry has asked 44 pharmaceutical companies, including global drug majors such as Eli Lilly, Novartis, Pfizer, Bayer, Merck, Johnson & Johnson and Sanofi Aventis, to explain why they have not given the compensation, which is mandatory under the current drug laws.
In an effort to improve their balance sheets, many of the major multinationals have started to lay-off employees.
The coronavirus dominated the opening minutes of the Trump-Biden face-off in Nashville with US President Trump terming the contagion a "worldwide problem".
'If at all there is going to be a second wave, it will not be very strong unlike in the US and Europe.'
The anti-depressant drug market in the US is primarily ruled by Effexor XR (Venlafaxine) of Wyeth (now owned by Pfizer).
Interacting with state chief ministers, Modi underscored the enormity of what he described as the world's biggest vaccination exercise, which begins from January 16, saying over 30 crore citizens will get the jabs in the next few months in India against only 2.5 crore people vaccinated so far in over 50 countries in around a month.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances